Submit manuscript...
Journal of
eISSN: 2373-6445

Psychology & Clinical Psychiatry

Editorial Volume 16 Issue 3

Suicide study, new approaches

Da-Yong Lu

School of Life Sciences, Shanghai University, China

Correspondence: Da-Yong Lu, School of Life Science, Shanghai University, Shanghai 200444, PRC, China

Received: May 26, 2025 | Published: June 9, 2025

Citation: Da-Yong L. Suicide study, new approaches. J Psychol Clin Psychiatry. 2025;16(3):87-88. DOI: 10.15406/jpcpy.2025.16.00816

Download PDF

Abstract

Human suicide lost many lives annually. The complex features of human suicide are waiting to be revealed. New prediction, prevention and countermeasure are emerging more recently. Yet, diagnostic and therapeutic study is needed in mortality reduction. Effective drugs and therapeutics are underway. In this editorial, different suicide treatment approaches are highlighted.

Keywords: suicide, medical research, diagnostics, mental illness

Introduction

Clinical scenario

Human suicide lost many life annually.1–3 The complex features of human suicide are waiting to be revealed. New prediction, prevention and countermeasure are emerging more recently.3–7 Yet, diagnostic and therapeutic study is needed in mortality reduction. Effective drugs and therapeutics are underway. In this editorial, different suicide treatment approaches are highlighted.

Knowledge evolution

The diagnostic and therapeutic studies were evolving across the history (Table 1).8–10

Timeline

Major discovery

Ancient Greece

Four elements and melancholy (excess of black bile)

Aretaeus of cappadocia

Clinical feature of depressive

Middle age

Patients with delusion

16th to 17th

Clinical diagnosis & behavior abnormal

18th

Nervous (animal spirits)

19th

Psychiatric symptoms

20th

Mood disorder & electroplexy & psychosurgery

Table 1 Historic order of suicide knowledge changes

These long processes are core areas for knowledge evolution and cutting-edge technology utilities.

Biology studies

Mental disorders has high rate of human deaths worldwide. The biomedical studies of mental diseases and suicide are the basic. The advanced genetic and molecular knowledge are reshaping the suicide treatment studies. The biomedical aspects of mental health problems were translated to high-quality suicide treatment.

The explorations of suicide and mental illness last to modern medicine. However, modern diagnostics (genes or molecular) is a new trend.11–15 Human suicides were reported to be controlled by drug, pleasant atmosphere and teenage education. The improved therapeutics should be discovered by adhering with modern biomedical studies.

Current achievements

Diagnostic insights: Psychiatric review is popular for clinicians or psychiatrists—score or rating for patients. Genetic platforms, like as pharmacogenetics (PG), sequencing, multi-omics or brain image are new frontiers to progress. The brain features of morphology see promising outcome in current studies.11–15 The genetic changes in many genes are under evaluations.16–19 At least 40 human genes are reported in human suicide. Many scientific research and challenge should be addressed in future.

To establish new suicide diagnostic platforms, brain image study is the key to popularized.20–25 These complex process studies four-fold increase in article number since 2005.26 More structural or functional variations have been discovered.

Clinical therapeutic studies

The progress of suicide studies is rapidly.27 Some antidepressants, especially selective serotonin reuptake inhibitor, SSRI show favorable outcomes in the clinic. In addition to antidepressants, other therapeutic selections, such as light therapy (physical treatment),28 emotional regulation,29 education for teenage30 are also useful for suicide reduction.

Computation and artificial intelligence

Mathematics or computation (artificial intelligence, AI) are playing important role. Mathematics methods or equation can increase way or latitude of problem thinking and solving.31,32 AI can simply these research and clinical application.33–35.

Future approaches

Genetic- or molecular-based suicide prediction and prevention system might be built in upcoming decades. After these studies, patient diagnostics will be quicker and low costs. Drug or other types therapeutics can be highly effective, personalized and usefulness. Investigational pathways are discussed as

  1. Biology, scoring and computational systems help clinical diagnosis and treatments
  2. Different algorithm or machine learning for initiating several workable paradigms for individual patients
  3. Establishing new diagnosis and treatments by modern technology (genetic, molecular and brain image)
  4. Collecting more biology and pathology data (genome-wide association study) in the clinic.
  5. Accumulating treatment data and algorithms for future referencing (big-data processing, machine-learning and deep learning)

Conclusions

Human suicidal study and application can save life of sufferers. Many new biomedical approaches between patients and normal people are highly needed. This kind of diagnosis, treatments and social integration may possibly help lives of patients and make this world more harmonies.

Acknowledgments

None.

Funding

None.

Conflicts of interest

Author declares there is no conflict of interest.

References

  1. Flach R, Fodor R, Kettel-Fulop F, et al. Myths about suicide-validating the Hungarian version of the literacy of suicide scale (H-LOSS) on a community sample. BMC Public Health. 2024;24(1):2351.
  2. Chahla MNA, Khalil M, Comai S, et al. Biological factors underpinning suicidal behavior: An update. Brain Sci. 2023;13(3):505.
  3. Lu DY. Suicide risks and treatments, new ideas and future perspectives. Ed Da-Yong Lu, Nova Science Publishers, New York, US, 2017.
  4. Serafini G, Salano P, Amore M. Suicidal ideation: a comprehensive overview. Suicidal ideation: predictors, prevalence and prevention. Ed. Bradley Weaver. Nova Science Publishing. US. 2015;Chapter 1:1–42.
  5. Lu DY, Lu TR, Lu Y, et al. Introduction for suicide study. J Metabolic Synd. 2017;6(2):227.
  6. Lu DY. Human suicide, biomedical knowledge and therapeutic advances. Hos Pal Med Int Jnl. 2024;7(3):92–94.
  7. Lu DY, Wu HY, Lu TR. Human suicide, an overview of management strategies. J Clin Medical Rev. 2024;3(2):1–6.
  8. Marreros A. Mood disorders: epidemiology and natural history. Psychiatry. 2008;8(2):52–55.
  9. Shandilya S. Suicide and suicide prevention: a historical review. Res J Social Sci. 2018;9:35–40.
  10. Lu DY, Wu HY, Cao S, et al. Historical analysis of suicide. J Transl Genet Genom. 2020;4:203–209.
  11. Lu DY, Lu TR, Che JY, et al. Genetics and bioinformatics studies of antidepressant drug therapeutic efficacies and toxicities, a current overview. Recent Pat CNS Drug Discov. 2014;9(3):193–199.
  12. Lu DY. Human suicide, clinical treatment overview. J Psychol Clin Psychiatry. 2025;16(1):24–28.
  13. Polo EP, Odife OA, Elusiyan TF. Utilitarian in suicide: insights from Freudian-Durkheimian theories and the response of Christian ethics. Nnadiebube J Soc Sci. 2025;5(1):39–50.
  14. Lu DY, Lu TR, Zhu PP, et al. The efficacies and toxicities of antidepressant drugs in clinics, building the relationship between Chemo-Genetics and Socio-Environments. Cent Nerv Syst Agents Med Chem. 2016;16(1):12–18.
  15. Lu DY, Wu HY. Neuropsychiatric insights for human suicide. Int J Scientific Res Updates. 2021;1(2):11–18.
  16. Malhotra D, Sebat J. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell. 2012;148(6):1223–1241.
  17. Krystal JH, State MW. Psychiatric disorders: diagnosis to therapy. Cell. 2014;157(1):201–214.
  18. Lu DY, Wu HY. Neuropsychiatric approaches for human suicide prediction and management. Int J Neuropsychol Behavioral Sci. 2021;2(3):87–91.
  19. Lu DY, Wu HY, Xu B, et al. Neurobiology for human suicide. Int J Sci Res Arch. 2021;2(2):120–125.
  20. Desmyter S, Bijttebier S, Heeringen KV. The role of neuroimaging in our understanding of the suicidal brain. CNS Neurol Disord Drug Targets. 2013;12(7):921–929.
  21. Lu DY, Lu TR, Zhu PP. Undesired neural side-effects of a drug, a chemical and genetic interrelated problem. Cent Nerv Syst Agents Med Chem. 2010;10(2):108–112.
  22. Horosan L, Nistor DE, Ion A, et al. Understanding suicide. Discoveries. 2024;12(1):e183.
  23. Lu DY. Is Tau molecule regarded as a risk factor for human suicide? Int J Psychiatry. 2023;8(2):28.
  24. Lu DY, Zhu PP, Wu HY, et al. Human suicide risk and treatment study. Cent Nerv Syst Agents Med Chem. 2018;18(3):206–212.
  25. Lu DY, Che JY, Wu HY, et al. Suicide risks and prevention, neuropathogenic study. EDEWEISS: Psychiatry. 2020;4(1):124.
  26. Mann JJ, Michel CA, Auerbach RP. Improving suicide prevention through evidence-based strategies: A systematic review. Am J Psychiatry. 2021;178(7):611–624.
  27. Lu DY, Zhu PP, Lu TR, et al. The suicidal risks and treatments, seek medications from multi-disciplinary. Cent Nerv Syst Agents Med Chem. 2016;16(3):231–239.
  28. Eagles JM. Light therapy and seasonal affective disorder. Psychiatry. 2009;8(4):125–129.
  29. Lu DY, Wu HY, Lu TR. Human suicide, management landscape. Psychology J Res Open. 2024;6(3):1–2.
  30. Rutz W. Preventing suicide and premature death by education and treatment. J Affect Disord. 2001;62:123–129.
  31. Lu DY, Lu TR. Human suicide risk study and treatment, a mathematical approach. J Mental Disord Treatment. 2018;4(2):161.
  32. Lu DY, Lu TR, Yarla NS. Human suicide study from mathematical approaches. Clin Biotechnology Microbiology. 2018;2(3):361–363.
  33. Huang DC, Yang MX, Wen X, et al. Al-driven drug discovery: accelerating the development of novel therapeutics in biopharmaceuticals. Int Med Sci Res J. 2024;4(8):882–899.
  34. Shinde PS, Pawar AY, Talele SG. The role of artificial intelligence in the pharmaceutical sector: a comprehensive analysis of its application from the discovery phase to industrial implementation. Int J Drug Delivery Technol. 2023;13(4):1578–1584.
  35. Dashpute SV, Pansare JJ, Deore YK, et al. Artificial intelligence and machine learning in the pharmaceutical industry. Int J Pharmacy Pharmac Res. 2023;28(2):111–131.
Creative Commons Attribution License

©2025 Da-Yong. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.